Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3257685rdf:typepubmed:Citationlld:pubmed
pubmed-article:3257685lifeskim:mentionsumls-concept:C0043250lld:lifeskim
pubmed-article:3257685lifeskim:mentionsumls-concept:C0043240lld:lifeskim
pubmed-article:3257685lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:3257685lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:3257685pubmed:issue3lld:pubmed
pubmed-article:3257685pubmed:dateCreated1988-3-23lld:pubmed
pubmed-article:3257685pubmed:abstractTextPreviously we have noted that fluid obtained from ten-day-old healing wounds noncytotoxically inhibits the blastogenesis of lymphocytes in response to mitogens or antigens. Since these lymphocytic responses are interleukin 2 (IL-2)-mediated, we looked for a specific IL-2 inhibitor in wound fluid. We have found that wound fluid blocks the response of thymic lymphocytes and of two cloned T-helper cell lines (D10 and HT2) to exogenous human recombinant IL-2. The wound fluid enhances fibroblast proliferation, thus demonstrating that its proliferative inhibitory activity is specific for lymphocytes. The findings suggest that wound fluid contains a factor that impairs lymphocyte response to IL-2, probably at the receptor or postreceptor level.lld:pubmed
pubmed-article:3257685pubmed:languageenglld:pubmed
pubmed-article:3257685pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3257685pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3257685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3257685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3257685pubmed:statusMEDLINElld:pubmed
pubmed-article:3257685pubmed:monthMarlld:pubmed
pubmed-article:3257685pubmed:issn0004-0010lld:pubmed
pubmed-article:3257685pubmed:authorpubmed-author:WasserkrugH...lld:pubmed
pubmed-article:3257685pubmed:authorpubmed-author:EfronGGlld:pubmed
pubmed-article:3257685pubmed:authorpubmed-author:BarbulAAlld:pubmed
pubmed-article:3257685pubmed:authorpubmed-author:KupperT STSlld:pubmed
pubmed-article:3257685pubmed:authorpubmed-author:BreslinR JRJlld:pubmed
pubmed-article:3257685pubmed:authorpubmed-author:Knud-HansenJ...lld:pubmed
pubmed-article:3257685pubmed:issnTypePrintlld:pubmed
pubmed-article:3257685pubmed:volume123lld:pubmed
pubmed-article:3257685pubmed:ownerNLMlld:pubmed
pubmed-article:3257685pubmed:authorsCompleteYlld:pubmed
pubmed-article:3257685pubmed:pagination305-8lld:pubmed
pubmed-article:3257685pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:meshHeadingpubmed-meshheading:3257685-...lld:pubmed
pubmed-article:3257685pubmed:year1988lld:pubmed
pubmed-article:3257685pubmed:articleTitleGeneration of an anti-interleukin 2 factor in healing wounds.lld:pubmed
pubmed-article:3257685pubmed:affiliationDepartment of Surgery, Sinai Hospital, Baltimore, MD 21215.lld:pubmed
pubmed-article:3257685pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3257685lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3257685lld:pubmed